Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1294943rdf:typepubmed:Citationlld:pubmed
pubmed-article:1294943lifeskim:mentionsumls-concept:C0520484lld:lifeskim
pubmed-article:1294943lifeskim:mentionsumls-concept:C0725066lld:lifeskim
pubmed-article:1294943lifeskim:mentionsumls-concept:C0332185lld:lifeskim
pubmed-article:1294943pubmed:issue41lld:pubmed
pubmed-article:1294943pubmed:dateCreated1993-4-12lld:pubmed
pubmed-article:1294943pubmed:abstractTextInterest in xenotransplantation has dramatically increased in the past 4 years, focusing on the potential use as donors of distantly related animals such as pigs (discordant xenografts). The major barrier is hyperacute rejection. The mechanisms responsible for this rejection include: specific reaction of the recipient's natural antibodies with antigens in the donor's organ, direct activation of the recipient's complement system by endothelial cells in the donor's organ, and/or relative failure of complement inhibitory proteins in the donor's organ to impede activation of the recipient's complement system. In case of vascularized xenograft, the temporary depletion of anti-donor antibodies (anti-ABH or anti-HLA class I) from a graft recipient may allow the long term survival of the graft despite a possible return of the antibodies to the circulation. This phenomenon is called accommodation. The mechanisms involved could be: the endothelial cells in a graft develop a resistance to complement mediated injury; the antigens expressed on the blood vessels become modulated or changed; the natural antibody repertoire changes in such a way that there are fewer anti-donor antibodies. The accommodation phenomenon encourages the view that the barrier to xenotransplantation is not immutable.lld:pubmed
pubmed-article:1294943pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1294943pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1294943pubmed:languagefrelld:pubmed
pubmed-article:1294943pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1294943pubmed:citationSubsetIMlld:pubmed
pubmed-article:1294943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1294943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1294943pubmed:statusMEDLINElld:pubmed
pubmed-article:1294943pubmed:monthDeclld:pubmed
pubmed-article:1294943pubmed:issn0755-4982lld:pubmed
pubmed-article:1294943pubmed:authorpubmed-author:JeffreyLLlld:pubmed
pubmed-article:1294943pubmed:authorpubmed-author:PlattM DMDlld:pubmed
pubmed-article:1294943pubmed:issnTypePrintlld:pubmed
pubmed-article:1294943pubmed:day2lld:pubmed
pubmed-article:1294943pubmed:volume21lld:pubmed
pubmed-article:1294943pubmed:ownerNLMlld:pubmed
pubmed-article:1294943pubmed:authorsCompleteYlld:pubmed
pubmed-article:1294943pubmed:pagination1932-8lld:pubmed
pubmed-article:1294943pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1294943pubmed:meshHeadingpubmed-meshheading:1294943-...lld:pubmed
pubmed-article:1294943pubmed:meshHeadingpubmed-meshheading:1294943-...lld:pubmed
pubmed-article:1294943pubmed:meshHeadingpubmed-meshheading:1294943-...lld:pubmed
pubmed-article:1294943pubmed:meshHeadingpubmed-meshheading:1294943-...lld:pubmed
pubmed-article:1294943pubmed:meshHeadingpubmed-meshheading:1294943-...lld:pubmed
pubmed-article:1294943pubmed:meshHeadingpubmed-meshheading:1294943-...lld:pubmed
pubmed-article:1294943pubmed:year1992lld:pubmed
pubmed-article:1294943pubmed:articleTitle[Recent advances in xenotransplantation].lld:pubmed
pubmed-article:1294943pubmed:publicationTypeEditoriallld:pubmed
pubmed-article:1294943pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1294943pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:1294943pubmed:publicationTypeReviewlld:pubmed
pubmed-article:1294943pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed